Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different?
Kowalski
M L
ML
Department of Clinical Immunology and Allergy, Medical University of Lodz, 92-215 Lodz, Poland. kowalsml@psk2.am.lodz.pl
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D009298:Nasal Polyps / Q000139:chemically induced; D012140:Respiratory Tract Diseases / Q000139:chemically induced*; D012220:Rhinitis / Q000139:chemically induced; D012852:Sinusitis / Q000139:chemically induced
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D001241:Aspirin